Operating Lease, Liability, Current of Pharma-Bio Serv, Inc. from 31 Oct 2019 to 31 Jul 2025

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
Summary
Pharma-Bio Serv, Inc. quarterly Operating Lease, Liability, Current in USD history and change rate from 31 Oct 2019 to 31 Jul 2025.
  • Pharma-Bio Serv, Inc. Operating Lease, Liability, Current for the quarter ending 31 Jul 2025 was $71,362, a 56% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Liability, Current, Quarterly (USD)
Operating Lease, Liability, Current, YoY Quarterly Change (%)

Pharma-Bio Serv, Inc. Quarterly Operating Lease, Liability, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $71,362 -$90,552 -56% 31 Jul 2025 10-Q 15 Sep 2025 2025 Q3
Q1 2025 $113,044 -$45,649 -29% 30 Apr 2025 10-Q 16 Jun 2025 2025 Q2
Q4 2024 $153,994 -$1,576 -1% 31 Jan 2025 10-Q 17 Mar 2025 2025 Q1
Q3 2024 $165,201 +$12,727 +8.3% 31 Oct 2024 10-Q 15 Sep 2025 2025 Q3
Q2 2024 $161,914 +$12,473 +8.3% 31 Jul 2024 10-Q 16 Sep 2024 2024 Q3
Q1 2024 $158,693 +$12,226 +8.3% 30 Apr 2024 10-Q 14 Jun 2024 2024 Q2
Q4 2023 $155,570 +$11,856 +8.2% 31 Jan 2024 10-Q 18 Mar 2024 2024 Q1
Q3 2023 $152,474 +$11,619 +8.2% 31 Oct 2023 10-K 29 Jan 2025 2024 FY
Q2 2023 $149,441 +$11,388 +8.2% 31 Jul 2023 10-Q 14 Sep 2023 2023 Q3
Q1 2023 $146,467 +$11,161 +8.2% 30 Apr 2023 10-Q 14 Jun 2023 2023 Q2
Q4 2022 $143,714 +$11,014 +8.3% 31 Jan 2023 10-Q 17 Mar 2023 2023 Q1
Q3 2022 $140,855 +$10,795 +8.3% 31 Oct 2022 10-K 29 Jan 2024 2023 FY
Q2 2022 $138,053 -$34,904 -20% 31 Jul 2022 10-Q 14 Sep 2022 2022 Q3
Q1 2022 $135,306 -$34,210 -20% 30 Apr 2022 10-Q 14 Jun 2022 2022 Q2
Q4 2021 $132,700 -$33,937 -20% 31 Jan 2022 10-Q 17 Mar 2022 2022 Q1
Q3 2021 $130,060 -$32,857 -20% 31 Oct 2021 10-K 30 Jan 2023 2022 FY
Q2 2021 $172,957 +$13,285 +8.3% 31 Jul 2021 10-Q 14 Sep 2021 2021 Q3
Q1 2021 $169,516 +$13,020 +8.3% 30 Apr 2021 10-Q 14 Jun 2021 2021 Q2
Q4 2020 $166,637 +$12,874 +8.4% 31 Jan 2021 10-Q 17 Mar 2021 2021 Q1
Q3 2020 $162,917 +$162,917 31 Oct 2020 10-K 11 Feb 2022 2021 FY
Q2 2020 $159,672 31 Jul 2020 10-Q 14 Sep 2020 2020 Q3
Q1 2020 $156,496 30 Apr 2020 10-Q 15 Jun 2020 2020 Q2
Q4 2019 $153,763 31 Jan 2020 10-Q 16 Mar 2020 2020 Q1
Q3 2019 $0 31 Oct 2019 10-K 01 Feb 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.